LIVEUPDATE

Breaking News & Latest News 

Subscribe
Clinical research results for Kelun-Biotech’s TROP2 ADC sacituzumab tirumotecan (sac-™T) published in Nature Medicine, a top international medical journal

Post Content

​ 

Leave a Reply

Your email address will not be published. Required fields are marked *